Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

5.1K
5.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lysozyme Amyloid for Synthetic RNA Delivery.

Pharmaceutics·2025
Same author

Effect of cellular polyanion mimetics on tau peptide aggregation.

Journal of peptide science : an official publication of the European Peptide Society·2018
Same author

Tau peptides and tau mutant protein aggregation inhibition by cationic polyethyleneimine and polyarginine.

Biopolymers·2017
See all related articles

Related Experiment Video

Updated: Jun 22, 2025

Fabrication of Amyloid-β-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease
06:52

Fabrication of Amyloid-β-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease

Published on: July 6, 2019

9.3K

Novel Ultrasound-Responsive Amyloid Formulation.

Maytham Ismail1, Mathumai Kanapathipillai1

  • 1Department of Mechanical Engineering, University of Michigan-Dearborn, Dearborn, MI 48128, USA.

Pharmaceuticals (Basel, Switzerland)
|June 27, 2024
PubMed
Summary

Novel amyloid aggregates from RIP3 peptide and Pluronic F127 show ultrasound-responsive drug delivery for lung cancer. These peptide aggregates efficiently deliver Doxorubicin, enhancing cancer cell toxicity.

Keywords:
RIP3amyloid aggregatesdrug deliverythermoresponsive polymer

More Related Videos

Delivery of Antibodies into the Brain Using Focused Scanning Ultrasound
07:34

Delivery of Antibodies into the Brain Using Focused Scanning Ultrasound

Published on: July 18, 2020

3.1K
A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis
06:17

A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis

Published on: May 22, 2018

11.9K

Related Experiment Videos

Last Updated: Jun 22, 2025

Fabrication of Amyloid-β-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease
06:52

Fabrication of Amyloid-β-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease

Published on: July 6, 2019

9.3K
Delivery of Antibodies into the Brain Using Focused Scanning Ultrasound
07:34

Delivery of Antibodies into the Brain Using Focused Scanning Ultrasound

Published on: July 18, 2020

3.1K
A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis
06:17

A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis

Published on: May 22, 2018

11.9K

Area of Science:

  • Biomaterials Science
  • Nanotechnology
  • Drug Delivery Systems

Background:

  • Amyloid aggregates are explored for biomedical applications, especially in drug delivery.
  • Developing stimuli-responsive drug delivery systems is crucial for targeted therapies.

Purpose of the Study:

  • To create novel amyloid aggregates using a RIP3 peptide and Pluronic F127 copolymer.
  • To evaluate the physicochemical and ultrasound-responsive properties of these aggregates.
  • To assess their potential as a drug depot for lung cancer treatment using Doxorubicin.

Main Methods:

  • Synthesis and characterization of RIP3/F127 amyloid aggregates.
  • Assessment of physicochemical properties (size, morphology, stimuli-responsiveness).
  • In vitro evaluation of drug delivery efficacy and cytotoxicity in lung cancer cells using Doxorubicin.

Main Results:

  • RIP3 and RIP3/F127 demonstrated amyloidogenic properties.
  • RIP3/F127 aggregates showed significant ultrasound responsiveness.
  • Ultrasound-treated RIP3/F127/Doxorubicin formulations enhanced lung cancer cell toxicity compared to Doxorubicin alone.

Conclusions:

  • Amyloidogenic peptide aggregates can be engineered with stimuli-responsive properties.
  • RIP3/F127 amyloid aggregates serve as efficient drug delivery depots.
  • Ultrasound-responsive amyloid aggregates show promise for targeted lung cancer therapy.